What Is Your Doctor Getting Paid?
The Physician Payments Sunshine Act requires that financial relationships between physicians and industry be made public on a government website known as Open Payments. Read More
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, September 30, 2014
Fourth Question of the Day September 30, 2014 The Physician Payments Sunshine Act requires that financial relationships between physicians and industry be made public on a government website known as Open Payments. Should there be a similar act requiring disclosure of pharmacists financial relationships, especially in light of all the overlapping ownership interest?
Subscribe to:
Post Comments (Atom)
1 comment:
Yes--pharmacies should be subject to the same level of transparency to the public, and so should chemical repackagers, who proffer deals that result in pharmacies making larger profits than they would normally if they chose to dispense nationally authorized products. This alerts consumers and payers that there may be strong financial incentives influencing professional's specific therapeutic recommendations--a dose of "healthy skepticism" is warranted (see: http://www.healthyskepticism.org/global/).
But current lack of transparency is only one determinant clouding medical and pharmacy decision-making in the promotion-frenzied compounded drug marketplace that can lead to increased risk or unfair transfer and distribution of risk to patients and subsequently, payers. Where there are outright kick-backs for prescribing, compensation for pseudo-trials, or gradually elevating AWPs for ingredients, fraud and abuse must be identified and vigorously prosecuted.
Post a Comment